Mittal's Florange site was in the news recently, after the government wanted the steel giant out of the country as it said that it doesn't respect France.
However, the big issues now seem to have settled down as the ArcelorMittal made a deal with the government, under which it would avoid the job cuts. The firm has agreed to government's suggestions and is planning to relocate the workers within the site.
It has said that it would keep the controversial furnaces at the site closed while it will move some of the workers to move to others jobs while the others will be granted retirement packages. It will also look forward to volunteer redundancies.
With the start of next year, the steel giant will invest a big sum of 18 million Euros at the Florange site. The investment will form a part of the five year investment strategy undertaken by the firm. It further said that it will invest 13 million Euros into research center at Maizieres-les-Metz to help itself cope up with the technical problems.
"We will continue to produce steel of the highest quality in France, and we will work to show our stakeholders in France that we are a company that delivers on its commitments", said Mittal.
In a recent announcement, Sega has revealed that its Steam catalog of classic Genesis and Mega Drive games is being updated with a new 3D interface --- the Sega Mega Drive Classics Hub.
Announcing the Classics Hub, Sega said that the new...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Wednesday, European competition authorities unveiled...
The button white mushroom edited using CRISPR has...
In a Tuesday announcement, Supergiant Games studio’s...
According to a CNN report, the Federal Investigation...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).